Commercialization of catalytic enhancers targeting IDO1 for multiple sclerosis

Project Information

ENHANCIDO

Grant agreement ID: 899838

DOI

10.3030/899838

Project closed

EC signature date 21 April 2020

Start date 1 September 2020

End date 31 August 2022

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

No data

EU contribution

€ 150 000,00

Coordinated by

UNIVERSITA DEGLI STUDI DI PERUGIA
Italy

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (4)

Polyamines and Kynurenines at the Intersection of Immune Modulation.

Author(s): Elisa Proietti; Sofia Rossini; Ursula Grohmann; Giada Mondanelli
Published in: Trends in Immunology, Issue 1, 2020, Page(s) 1037 - 1050, ISSN 1471-4906
Publisher: Elsevier BV
DOI: 10.1016/j.it.2020.09.007

Amino Acid Metabolism in Rheumatoid Arthritis: Friend or Foe?

Author(s): Eleonora Panfili; Roberto Gerli; Ursula Grohmann; Maria Teresa Pallotta
Published in: Biomolecules, Issue 1, 2020, Page(s) 1 - 22, ISSN 2218-273X
Publisher: MDPI
DOI: 10.3390/biom10091280

Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme

Author(s): Maria Teresa Pallotta; Sofia Rossini; Chiara Suvieri; Alice Coletti; Ciriana Orabona; Antonio Macchiarulo; Claudia Volpi; Ursula Grohmann
Published in: The FEBS Journal, Issue 1, 2021, ISSN 1742-464X
Publisher: Blackwell Publishing Inc.
DOI: 10.1111/febs.16086

Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls

Author(s): Andrea Mammoli; Elisa Bianconi; Luana Ruta; Alessandra Riccio; Carlo Bigiotti; Maria Souma; Andrea Carotti; Sofia Rossini; Chiara Suvieri; Maria Teresa Pallotta; Ursula Grohmann; Emidio Camaioni; Antonio Macchiarulo
Published in: International Journal of Molecular Sciences, Issue 2, 2022, Page(s) 3981, ISSN 1661-6596
Publisher: MDPI Center
DOI: 10.3390/ijms23073981

Non-peer reviewed articles (1)

Reply to Han et al.: On track for an IDO1-based personalized therapy in autoimmunity

Author(s): Giada Mondanelli, Agostinho Carvalho, Paolo Puccetti, Ursula Grohmann, Claudia Volpi
Published in: Proceedings of the National Academy of Sciences of the United States of America, 2020, Page(s) 24037 - 24038, ISSN 0027-8424
Publisher: National Academy of Sciences
DOI: 10.1073/pnas.2016277117